Endovascular Management of Dural Arteriovenous Malformations

Endovascular neurosurgery has evolved dramatically since the first description of aneurysm coiling in 1991 and is now employed as a primary treatment strategy for managing a multitude of cerebrovascular pathologies, including aneurysms, arteriovenous malformations (AVMs), and acute ischemic stroke. The endovascular approach offers an attractive, minimally invasive alternative for aneurysm treatment with low procedure-related morbidity and mortality. The durability and long-term efficacy of endovascular interventions is continuously evolving, especially with the introduction of newer coils, stents, and flow-diversion techniques. Endovascular management of AVMs can be used for presurgical embolization, preradiosurgical intervention, or palliative embolization or as a primary treatment for curative embolization, depending on the characteristics of the lesion. Advances in endovascular management of acute stroke have further increased the therapeutic window of recombinant tissue plasminogen activator administration using the intraarterial route and have led to the introduction of new devices for clot removal and vessel recanalization.

Download Full-text

Endovascular management of uterine arteriovenous malformations: causes, clinical presentation, technique and outcomes

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2013.12.504 ◽

2014 ◽

Vol 25 (3) ◽

pp. S187

Author(s):

A.K. Abdel Aal ◽

M.W. Estafanous ◽

L. Anis Estafanous ◽

R. Oser ◽

S. Saddekni ◽

...

Keyword(s):

Arteriovenous Malformations ◽

Clinical Presentation ◽

Endovascular Management

Download Full-text

Embolization of spinal cord arteriovenous malformations with an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (Onyx liquid embolic system)

Journal of Neurosurgery Spine ◽

10.3171/spi.2000.93.2.0304 ◽

2000 ◽

Vol 93 (2) ◽

pp. 304-308 ◽

Cited By ~ 4

Author(s):

Andrew J. Molyneux ◽

Stuart C. Coley

Keyword(s):

Spinal Cord ◽

Arteriovenous Malformations ◽

Embolic Agent ◽

Endovascular Management ◽

Content Type ◽

Ethylene Vinyl Alcohol ◽

Promising Agent ◽

Liquid Embolic ◽

Liquid Embolic Agent ◽

Brain Avms

✓ In this paper the authors describe the first use of a new liquid embolic agent (Onyx) to treat spinal cord arteriovenous malformations (AVMs). Because its properties make it more predictable to use than currently available liquid agents, the authors believe that this material has great potential in the endovascular management of both spinal cord and brain AVMs. This very promising agent merits further clinical study.

Download Full-text